We also provide evidence that IFN regulatory factor 1 (IRF1), an important contributor to type I IFN signature in SLE, is part of the DDR machinery mediating ATR pathway activation in IFN-α–treated B cells. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.